← back to dashboard

HURA

TuHURA Biosciences, Inc./NV
Composite
0.05
EDGAR
0.05
Filings (90d)
8
Peak
0.03
Last Signal
2026-08-21T17:00

All Filings

Filed Form Items Signal Score Summary Link
2026-08-21 17:00 8-K ["2.03", "9.01"] other 0.05 Routine loan draw under existing credit facility; no M&A signals present. SEC · detail
2026-08-19 17:00 8-K ["3.02", "5.07", "9.01"] other 0.05 Routine 8-K reporting annual meeting results, equity issuance, and director elections. No M&A signals. SEC · detail
2026-08-14 07:50 8-K ["2.02", "9.01"] other 0.05 Routine earnings report and corporate update filing; no M&A signals detected. SEC · detail
2026-08-13 17:00 8-K ["2.03", "9.01"] other 0.05 Routine debt draw ($650K) under existing revolving credit facility; no M&A signals. SEC · detail
2026-07-29 17:00 8-K ["2.03", "9.01"] other 0.05 Routine loan draw under existing revolving credit facility; no M&A signals. SEC · detail
2026-07-07 17:30 8-K ["2.03", "9.01"] other 0.05 Routine loan draw under existing revolving credit facility; no M&A signals. SEC · detail
2026-06-17 16:30 8-K ["5.08"] other 0.05 Routine 8-K announcing 2026 Annual Meeting date and shareholder proposal deadlines; no M&A signals. SEC · detail
2026-05-29 17:00 8-K ["2.03", "9.01"] other 0.05 8-K reports routine loan draw from existing facility; no M&A signals present. SEC · detail
2026-05-15 17:10 8-K ["2.02", "7.01", "9.01"] other 0.05 Routine Q1 2026 earnings release with investor presentation; no M&A signals detected. SEC · detail
2026-04-30 16:45 8-K ["8.01", "9.01"] other 0.00 Post-closing amendment correcting pro forma financials from completed Kineta acquisition; no forward M&A signal. SEC · detail